The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 23, 2016
Filed:
Feb. 10, 2015
Applicant:
Critical Outcome Technologies Inc., London, CA;
Inventors:
Wayne Danter, London, CA;
Clinton Threlfall, London, CA;
Sylvain Guizzetti, Illkirch Cedex, FR;
Julien Marin, Illkirch Cedex, FR;
Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/04 (2006.01); C07D 239/36 (2006.01); C07D 239/40 (2006.01); C07D 239/42 (2006.01); C07D 413/04 (2006.01); C07D 239/47 (2006.01); C07D 239/557 (2006.01); C07D 239/56 (2006.01); C07D 487/04 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); C07D 239/36 (2013.01); C07D 239/40 (2013.01); C07D 239/42 (2013.01); C07D 239/47 (2013.01); C07D 239/557 (2013.01); C07D 239/56 (2013.01); C07D 413/04 (2013.01); C07D 487/04 (2013.01);
Abstract
The invention relates to a compound of Formulae I and/or II: and/or a pharmaceutically-acceptable salt, hydrate, solvate, tautomer, optical isomer, E-isomer, Z-isomer, or combination thereof; X is selected from Se, N—OH, NH, NO, CN, N—CN, N═O, O or S, and the remaining substituents are described herein; and a composition thereof. The invention also relates to a method of administration thereof; and use thereof to treat HIV.